Berfu Korucu, Joyce Xu, Henrike Hamer, Robert de Jonge, Serpil Muge Deger, Marc Vervloet
{"title":"Effect of Medium Cut-Off Dialyzers on Calcification Propensity in Hemodialysis Patients: A 6-Month Prospective Pilot Study","authors":"Berfu Korucu, Joyce Xu, Henrike Hamer, Robert de Jonge, Serpil Muge Deger, Marc Vervloet","doi":"10.1111/hdi.70033","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>T50 is a serum-based measure of calcification propensity and a predictor of cardiovascular risk and mortality in hemodialysis (HD) patients. Cardiovascular disease is in part driven by uremic toxins. Medium cut-off (MCO) dialyzers enhance the clearance of middle molecular weight (MW) uremic toxins compared to conventional dialyzers. However, the long-term impact of MCO dialyzers on pre-dialysis and post-dialysis T50 scores remains unknown.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>The study included maintenance HD patients on low-flux (LF) dialyzers. Pre- and post-dialysis serum samples were collected in mid-week HD sessions: first with LF dialyzers (baseline) and then 6 months after switching to MCO dialyzers. Change in T50 was analyzed for a single HD treatment under LF and MCO dialyzers, and baseline and sixth-month pre-dialysis T50 scores were compared.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Fifteen patients were included. Pre- and post-dialysis percent improvement in T50 for LF and MCO dialyzers were similar (85.2% [45.0, 282.7] and 56.3% [21.1, 238.6], respectively, <i>p</i> = 0.35). Pre-dialysis T50 after 6 months on MCO was comparable to the baseline (<i>p</i> = 0.73). Pre-dialysis T50 at baseline had an inverse association with improvement in T50 after a single HD treatment (<i>β</i> = −0.88; 95% CI: −1.18 to −0.57; <i>p</i> < 0.01), and smoking had a direct association with pre-dialysis T50 after 6 months of MCO treatment (<i>β</i> = −172; 95% CI: −287 to −56.8; <i>p</i> = 0.02).</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>MCO dialyzers do not confer additional benefits in improving serum calcification propensity, compared to LF dialyzers. Our data do not support a significant contribution of middle MW uremic toxins' removal to T50 scores.</p>\n </section>\n </div>","PeriodicalId":12815,"journal":{"name":"Hemodialysis International","volume":"30 1","pages":"168-175"},"PeriodicalIF":1.4000,"publicationDate":"2025-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hemodialysis International","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/hdi.70033","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background
T50 is a serum-based measure of calcification propensity and a predictor of cardiovascular risk and mortality in hemodialysis (HD) patients. Cardiovascular disease is in part driven by uremic toxins. Medium cut-off (MCO) dialyzers enhance the clearance of middle molecular weight (MW) uremic toxins compared to conventional dialyzers. However, the long-term impact of MCO dialyzers on pre-dialysis and post-dialysis T50 scores remains unknown.
Methods
The study included maintenance HD patients on low-flux (LF) dialyzers. Pre- and post-dialysis serum samples were collected in mid-week HD sessions: first with LF dialyzers (baseline) and then 6 months after switching to MCO dialyzers. Change in T50 was analyzed for a single HD treatment under LF and MCO dialyzers, and baseline and sixth-month pre-dialysis T50 scores were compared.
Results
Fifteen patients were included. Pre- and post-dialysis percent improvement in T50 for LF and MCO dialyzers were similar (85.2% [45.0, 282.7] and 56.3% [21.1, 238.6], respectively, p = 0.35). Pre-dialysis T50 after 6 months on MCO was comparable to the baseline (p = 0.73). Pre-dialysis T50 at baseline had an inverse association with improvement in T50 after a single HD treatment (β = −0.88; 95% CI: −1.18 to −0.57; p < 0.01), and smoking had a direct association with pre-dialysis T50 after 6 months of MCO treatment (β = −172; 95% CI: −287 to −56.8; p = 0.02).
Conclusion
MCO dialyzers do not confer additional benefits in improving serum calcification propensity, compared to LF dialyzers. Our data do not support a significant contribution of middle MW uremic toxins' removal to T50 scores.
期刊介绍:
Hemodialysis International was originally an annual publication containing the Proceedings of the International Symposium on Hemodialysis held in conjunction with the Annual Dialysis Conference. Since 2003, Hemodialysis International is published quarterly and contains original papers on clinical and experimental topics related to dialysis in addition to the Annual Dialysis Conference supplement. This journal is a must-have for nephrologists, nurses, and technicians worldwide. Quarterly issues of Hemodialysis International are included with your membership to the International Society for Hemodialysis.
The journal contains original articles, review articles, and commentary to keep readers completely updated in the field of hemodialysis. Edited by international and multidisciplinary experts, Hemodialysis International disseminates critical information in the field.